Skip to main content
SpringerLink
Log in

Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A hallmark of Type 2 diabetes mellitus (T2DM) is chronic hyperglycemia, which is thought to play a role in pancreatic β-cell failure. Here we investigated whether treatment of Zucker diabetic fatty (ZDF) rats, an animal model for T2DM, with the renal glucose transport inhibitor phlorizin could prevent alterations in the pancreatic islets. ZDF rats were treated with phlorizin or vehicle for 13 weeks starting with 6-weekold rats and before the onset of hyperglycemia. During the treatment, blood glucose levels in sham-treated ZDF rats increased rapidly from 7.7±0.3 to 24.8±0.6 mmol/l, whereas those in phlorizin-treated ZDF rats increased only slightly, but significantly, from 7.0±0.2 to 8.9±0.6 mmol/l. Phlorizin prevented the decrease in plasma insulin levels and caused a higher increase in body weight of the ZDF rats. Compared to 6-week-old untreated ZDF rats, in 19-week-old sham- and phlorizin-treated ZDF rats similar changes were found in islet architecture (more irregular boundaries and a disrupted mantle of peripheral islet cells) and in the mitochondria at the ultrastructural level (swelling of the matrix and disruption of the cristae). Using reverse transcriptase-polymerase chain reaction, no differences in mRNA expression levels were found for insulin, islet amyloid polypeptide (IAPP), and the prohormone convertase (PC) 1 and PC2 between 6-week-old untreated ZDF rats and 19-week-old sham- and phlorizin-treated ZDF rats. However, immunohistochemistry revealed similar decreases in insulin and IAPP protein expression in 19-week-old sham- and phlorizin-treated ZDF rats compared to those in 6-week-old untreated ZDF rats. These observations indicate that during aging of ZDF rats phlorizin treatment does not prevent the decreases in insulin and IAPP protein expression and the progressive histopathological changes in the pancreatic islets. Therefore, it is highly unlikely that these changes are caused by chronic hyperglycemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weir G.C., Leahy J.L. Pathogenesis of non-insulin-dependent (Type II) diabetes mellitus. In: Kahn C.R., Weir G.C. (Eds.), Joslin’s Diabetes Mellitus. Lea and Febiger, Philadelphia, 1994, p. 240.

    Google Scholar 

  2. Polonsky K.S., Sturis J., Bell G.I. Non-insulin-dependent diabetes mellitus — a genetically programmed failure of the β cell to compensate for insulin resistance. N. Engl. J. Med. 1996, 334: 777–783.

    Article  PubMed  CAS  Google Scholar 

  3. Welsh M. Glucose regulation of insulin gene expression. Diabetes Metab. 1989, 15: 367–371.

    CAS  Google Scholar 

  4. Philippe J. Structure and pancreatic expression of the insulin and glucagon genes. Endocr. Rev. 1991, 12: 252–271.

    Article  PubMed  CAS  Google Scholar 

  5. Giddings S.J., Chirgwin J.M., Permutt M.A. Glucose regulated insulin biosynthesis in isolated rat pancreatic islets is accompanied by changes in proinsulin mRNA. Diabetes Res. 1985, 2: 71–75.

    PubMed  CAS  Google Scholar 

  6. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995, 44: 863–870.

    Article  PubMed  CAS  Google Scholar 

  7. Leahy J.L. Detrimental effects of chronic hyperglycemia on the pancreatic β-cell. In: LeRoith D., Taylor S.I., Olefsky J.M. (Eds.), Diabetes Mellitus. Lippincott Williams and Wilkins, Philadelphia, 2000, p. 115.

    Google Scholar 

  8. Janssen S.W.J., Hermus A.R.M.M., Lange W.P.H. et al. Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats. Exp. Clin. Endocrinol. Diabetes 2001, 109: 273–282.

    Article  PubMed  CAS  Google Scholar 

  9. Höppener J.W., Ahren B., Lips C.J. Islet amyloid polypeptide and Type 2 diabetes mellitus. N. Engl. J. Med. 2000, 343: 411–419.

    Article  PubMed  Google Scholar 

  10. Clark J.B., Palmer C.J., Shaw W.N. The diabetic Zucker fatty rat. Proc. Soc. Exp. Biol. Med. 1983, 173: 68–75.

    Article  PubMed  CAS  Google Scholar 

  11. Tokuyama Y., Sturis J., DePaoli A.M., et al. Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 1995, 44: 1447–1457.

    Article  PubMed  CAS  Google Scholar 

  12. Janssen S.W.J., Martens G.J.M., Sweep C.G.J., Ross H.A., Hermus A.R.M.M. In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight. Horm. Metab. Res. 1999, 31: 610–615.

    Article  PubMed  CAS  Google Scholar 

  13. Rossetti L., Smith D., Shulman G.I., Papachristou D., DeFronzo R.A. Correction of hyperglycaemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 1987, 79: 1510–1515.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  14. Orci L., Ravazzola M., Baetens D., et al. Evidence that downregulation of β-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia. Proc. Natl. Acad. Sci. USA 1990, 87: 9953–9957.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. Ohneda M., Inman L.R., Unger R.H. Caloric restriction in obese pre-diabetic rats prevents β-cell depletion, loss of β-cell GLUT 2 and glucose incompetence. Diabetologia 1995, 38: 173–179.

    Article  PubMed  CAS  Google Scholar 

  16. Higa M., Zhou Y.T., Ravazzola M., Baetens D., Orci L., Unger R.H. Troglitazone prevents mitochondrial alterations, β cell destruction, and diabetes in obese prediabetic rats. Proc. Natl. Acad. Sci. USA 1999, 96: 11513–11518.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Zucker L.M., Zucker T.F. Fatty, a new mutation in the rat. J. Hered. 1961, 52: 275–278.

    Google Scholar 

  18. Pelleymounter M.A., Cullen M.J., Baker M.B., et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269: 540–543.

    Article  PubMed  CAS  Google Scholar 

  19. Griffen S.C., Wang J., German M.S. A genetic defect in β-cell gene expression segregates independently from the fa locus in the ZDF rat. Diabetes 2001, 50: 63–68.

    Article  PubMed  CAS  Google Scholar 

  20. Lee Y., Hirose H., Ohneda M., Johnson J.H., McGarry J.D., Unger R.H. β-cell lipotoxicity in the pathogenesis of noninsulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc. Natl. Acad. Sci. USA 1994, 91: 10878–10882.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  21. Shimabukuro M., Zhou Y.T., Lee Y., Unger R.H. Troglitazone lowers islet fat and restores β cell function of Zucker diabetic fatty rats. J. Biol. Chem. 1998, 273: 3547–3550.

    Article  PubMed  CAS  Google Scholar 

  22. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acidinduced β cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. USA 1998, 95: 2498–2502.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  23. Kaneto H., Fujii J., Seo H.G., et al. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 1995, 44: 733–738.

    Article  PubMed  CAS  Google Scholar 

  24. Bailyes E.M., Shennan K.I.J., Seal A.J., et al. A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the Type 1 proinsulin-converting endopeptidase. Biochem. J. 1992, 285: 391–394.

    PubMed Central  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Animal Physiology, Faculty of Science, University of Nijmegen, Nijmegen, The Netherlands

    S. W. J. Janssen & G. J. M. Martens

  2. Department of Endocrinology, University Medical Centre Nijmegen, Nijmegen, The Netherlands

    S. W. J. Janssen &  A. R. M. M. Hermus

  3. Department of Chemical Endocrinology, University Medical Centre Nijmegen, Nijmegen, The Netherlands

    C. G. J. Sweep & P. N. Span

  4. Department of Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands

    A. A. J. Verhofstad

Authors
  1. S. W. J. Janssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. J. M. Martens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. G. J. Sweep
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. N. Span
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. A. J. Verhofstad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. R. M. M. Hermus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. R. M. M. Hermus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janssen, S.W.J., Martens, G.J.M., Sweep, C.G.J. et al. Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats. J Endocrinol Invest 26, 508–515 (2003). https://doi.org/10.1007/BF03345212

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345212

Key-words

Search

Navigation